Differential Impact of Admission C-Reactive Protein Levels on 28-Day Mortality Risk in Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry)

American Journal of Cardiology

Volumn 102, Issue 9, 2008, Pages 1125-1130

  Kuch, Bernhard ^a   von Scheidt, Wolfgang ^a   Kling, Birgitt ^a   Heier, Margit ^b,c   Hoermann, Allmut ^b   Meisinger, Christa ^b,c  

^a Teaching Hospital   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY HOSPITAL AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; DISEASE REGISTRY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

ADULT; AGED; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TROPONIN I; TROPONIN T;

EID: 54549125894     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.034     Document Type: Article

References (30)

1. Toss H., Lindahl B., Siegbahn A., Wallentin L., and The FRagmin during InStability in Coronary artery disease (FRISC) Study Group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96 (1997) 4204-4210
2. Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L., and The FRagmin during InStability in Coronary artery disease (FRISC) Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 343 (2000) 1139-1147
3. Heeschen C., Hamm C.W., Bruemmer J., Simoons M.L., and The Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment (CAPTURE) Investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. J Am Coll Cardiol 35 (2000) 1535-1542
4. WHO MONICA Project Principal Investigators. World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 41 (1988) 105-114
5. Kuch B., Bolte H.D., Hörmann A., Meisinger C., and Löwel H. What is the real hospital mortality from acute myocardial infarction?. Epidemiological vs. clinical view. Eur Heart J 23 (2002) 714-720
6. Meisinger C., Hörmann A., Heier M., Kuch B., and Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol 113 (2006) 229-235
7. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
8. Kuch B., von Scheidt W., Kling B., Heier M., Hörmann A., and Meisinger C. Characteristics and outcome of patients with acute myocardial infarction according to presenting electrocardiogram (from the MONICA/KORA Augsburg Myocardial Infarction Registry). Am J Cardiol 100 (2007) 1056-1060
9. Rebuzzi A.G., Quaranta G., Liuzzo G., Caligiuri G., Lanza G.A., Gallimore J.R., Grillo R.L., Cianflone D., Biasucci L.M., and Maseri A. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 82 (1998) 715-719
10. Tomoda H., and Aoki N. Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J 140 (2000) 324-328
11. de Winter R.J., Heyde G.S., Koch K.T., Fischer J., van Straalen J.P., Bax M., Schotborgh C.E., Mulder K.J., Sanders G.T., Piek J.J., and Tijssen J.G. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J 23 (2002) 960-966
12. Sanchez P.L., Palacios I.F., Pobon P., Santos I., Rodriguez M.V., Villacorta E., Martin-Moreiras J., Cruz I., and Martin-Luengo C. Relationship between C-reactive protein and the electrocardiographic pattern on admission in patients with acute coronary syndrome. Cardiology 104 (2005) 45-50
13. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B., and The European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349 (1997) 462-466
14. van der Wal A.C., Becker A.E., van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36-44
15. Moghbeli N., Kirtane A.J., Ray K.K., Murphy S.A., Gibson C.M., Braunwald E., Cannon C.P., and TIMI Study Group. C-Reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial). Am J Cardiol 96 (2005) 635-638
16. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
17. Lindahl B., Venge P., and Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary disease: the FRISC Study Group. Circulation 93 (1996) 1651-1657
18. Ohman E., Armstrong P., Christenson R., Granger C.B., Katus H.A., Hamm C.W., O'Hanesian M.A., Wagner G.S., Kleiman N.S., Harrell Jr. F.E., Califf R.M., and Topol E.J. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 335 (1996) 1333-1341
19. Hamm C., Ravkilde J., Gerhardt W., Jørgensen P., Peheim E., Ljungdahl L., Goldmann B., and Katus H.A. The prognostic value of serum troponin T in unstable angina. N Engl J Med 327 (1992) 146-150
20. Foussas S.G., Zairis M.N., Makrygiannis S.S., Manousakis S.J., Anastassiadis F.A., Apostolatos C.S., Patsourakos N.G., Glyptis M.P., Papadopoulos J.K., Xenos D.C., et al. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction. Heart 93 (2007) 952-956
21. Kurowski V., Hartmann F., Killermann D.P., Giannitsis E., Wiegand U.K., Frey N., Müller-Bardorff M., Richardt G., and Katus H.A. Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction. Crit Care Med 30 (2002) 2229-2235
22. Giannitsis E., Müller-Bardorff M., Lehrke S., Wiegand U., Tölg R., Weidtmann B., Hartmann F., Richardt G., and Katus H.A. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation 104 (2001) 630-635
23. James S.K., Armstrong P., Barnathan E., Califf R., Lindahl B., Siegbahn A., Simoons M.L., Topol E.J., Venge P., Wallentin L., and GUSTO-IV-ACS Investigators. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. J Am Coll Cardiol 41 (2003) 916-924
24. Celik T., Iyisoy A., Kursaklioglu H., Turhan H., Kilic S., Kose S., Amasyali B., and Isik E. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Coron Artery Dis 16 (2005) 293-299
25. Zairis M.N., Manousakis S.J., Stefanidis A.S., Papadaki O.A., Andrikopoulos G.K., Olympios C.D., Hadjissavas J.J., Argyrakis S.K., and Foussas S.G. C-Reactive protein levels on admission are associated with response to thrombolytic and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 144 (2002) 782-789
26. Canale M.L., Stroppa S., Caravelli P., Petronio A.S., Mariotti R., Mariani M., Balbarini A., and Barsotti A. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation. Coron Artery Dis 17 (2006) 693-698
27. Mulvihill N.T., and Foley J.B. Inflammation in acute coronary syndromes. Heart 87 (2002) 201-204
28. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., and Maseri A. The prognostic value of C-reactive protein and serum amyoid A protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
29. Lagrand W.K., Visser C.A., Hermens W.T., Niessen H.W., Verheugt F.W., Wolbink G.J., and Hack C.E. C-Reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999) 96-102
30. De Servi S., Mariani M., Mariani G., and Mazzone A. C-Reactive protein increase in unstable coronary disease: cause or effect?. J Am Coll Cardiol 46 (2005) 1496-1502